Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice

James D Douketis1, Alex C Spyropoulos2, M Hassan Murad3

  • 1Department of Medicine, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, ON, Canada.

Chest
|August 14, 2022
PubMed

Insights

This guideline provides recommendations for managing antithrombotic therapy during surgery. Key findings include avoiding heparin bridging for atrial fibrillation patients and continuing warfarin for pacemaker implantations.

Area of Science:

  • Cardiology
  • Hematology
  • Surgery

Background:

  • Addresses perioperative management of patients on long-term oral anticoagulants or antiplatelet therapy undergoing elective procedures.
  • Covers four categories: vitamin K antagonists (VKAs), VKA with heparin bridging, direct oral anticoagulants (DOACs), and antiplatelet drugs.

Framework:

  • Utilizes the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology.
  • Generates practice recommendations based on evidence certainty (high, moderate, low, very low).

Implementation:

  • Provides 44 guideline recommendations for managing VKAs, heparin bridging, DOACs, and antiplatelet drugs.
  • Includes specific recommendations for minor procedures like dental, dermatologic, ophthalmologic, pacemaker/ICD implantation, and GI endoscopy.
  • Strong recommendations include against heparin bridging in atrial fibrillation and continuing VKA for pacemaker/ICD implantation.

Implications:

  • Incorporates substantial new evidence since the 2012 guidelines, particularly for VKA, DOAC, and antiplatelet management.
  • Highlights remaining uncertainties in perioperative management for many clinical questions.
  • Aims to optimize patient care and reduce bleeding/thrombotic risks in surgical settings.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
39
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
32
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
19
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
23
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
21